Corona virus vaccine trials by Pharmaceutical companies
As Corona cases are increasing, here is some good news. The pharmaceutical company, Zydus Cadila announced that it has started human trials of its vaccine, Zycov-D. Last month Drug Controller General of India (DGCI) has given approval for conducting human trials. The first patient has a given dose and thousands of volunteers have expressed the desire for conducting trials on them.
Phase -I & Phase -II of the clinical trials will be done one after the other in a quick time. The first batch of 1000 people will be selected for Phase-I.
The company selected healthy men and women between 18- 55 years of age group for trials. The company claims its plasmid DNA vaccine is safe for use without any side effects. For Phase-I trials, persons above 12 years will be selected.
There is increased pressure on Health infrastructure as thousands of new cases are registering every single day. Earlier, Hetero Drugs, Cipla, and Glenmark have completed all necessary permission to release Covid-19 drugs in the market.
Remedesivir drug which is effective in treating coronavirus is available for treatment are products of Hetero and Cipla. They got the license to market in India. But it is currently available in Hyderabad, Delhi, Gujarat, Maharastra, Tamilnadu, and Delhi
Favipiravir based drug by the brand name Fabiflu has been available in the market in the tablets form is the product of Glenmark pharma
Now another pharmaceutical giant, Astra Zeneca in association with oxford university has conducted initial trials and is expected to give results on the effectiveness of the drug.
Moderna company has started a phase -II trial of its own drug and will speed up the process to get the drug into the market if it is successful
Bharat Biotech in association with the Indian Council for Medical Research and National Institute of Virology, Pune, has developed a drug named Covaxin. They have started the Phase-I trials in 12 hospitals across India
Governments across the world should provide special schemes for the poor as they lost livelihood due to covid-19
Article Directory /
Arts, Business, Computers, Finance, Games, Health, Home, Internet, News, Other, Reference, Shopping, Society, Sports